Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-05-29
1999-10-05
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514323, 514380, 514386, 514414, A61K 31415, C07D23104
Patent
active
059624965
ABSTRACT:
This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 wherein R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2;
REFERENCES:
patent: 5145845 (1992-09-01), Johnson et al.
patent: 5256673 (1993-10-01), Bottcher et al.
patent: 5334606 (1994-08-01), Macleod
patent: 5418237 (1995-05-01), Bottcher et al.
patent: 5532241 (1996-07-01), Bottcher et al.
Cugola Alfredo
Di Fabio Romano
Pentassuglia Giorgio
Glaxo Wellcome SpA
McKane Joseph K.
LandOfFree
Indole derivatives as NMDA antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives as NMDA antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives as NMDA antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171985